ReviewDrugs2023
Targeting IL-23 for IBD: Rationale and Progress to Date.
Sudheer K Vuyyuru et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this paperpooled itcites it
ReviewDrugs2023
Sudheer K Vuyyuru et al.PubMed ↗Publisher ↗
No numbers read from the abstract.